Curcumin and its analogs (like PGV-1—pentagamavunone-1, and CCA-1.1—chemoprevention-curcumin analog-1.1) demonstrate promising anti-cancer effects in glioblastoma by modulating the p53 pathway, a critical regulator of cell cycle and apoptosis [100]. Here, TP53 is linked to cancer.